RLYB
Rallybio Corporation
NASDAQ · USHealthcareBiotechnology
$16.71+1.77%
Price as of Jul 20, 2026
RLYB analysis
Rallybio Corporation stock analysis
Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.
Analysis for RLYB is not published yet
Browse the public research library while company-specific analysis is being prepared. Explore research